Honeywell Signs Agreements to Advance Digitalization of Healthcare Globally

Honeywell (Nasdaq: HON) announced today its commitment to developing technology-led solutions for the future of healthcare delivery. Building on its deep expertise in the hospital setting, Honeywell signed Memorandums of Understanding (MOUs) with two leading healthcare companies with further collaborations to potentially follow in the United States and around the world.

The agreements provide a framework to co-innovate error-prone processes and tasks, enhance the patient experience and improve operational agility through digitalization.

COVID-19 highlighted the need for bringing efficiencies in healthcare delivery. From developing sensors and switch solutions that enhance the performance and reliability of ventilators, to protecting frontline workers with personal protective equipment, Honeywell has made significant investments in helping the industry respond to the COVID-19 pandemic. With one of the broadest portfolios of products for the healthcare environment, Honeywell’s engineered solutions provide the quality, durability and value needed to help deliver safer, more effective healthcare.

“The past few years have presented a myriad of challenges for already-stretched health systems and we’re not out of the woods yet. Over the next few years, the healthcare industry is expected to face an even greater surge in demand coupled with more rigorous cost-control pressures,” said Robert Robinson, vice president and general manager, Honeywell Healthcare Solutions. “Honeywell is committed to helping the industry respond to these challenges. We envision a future where every patient has access to quality, secure and effective care and every caregiver has access to digital tools that make their jobs easier and more efficient. We’re prepared to play a critical role in delivering on this vision and shaping the future of healthcare.”

As part of its commitment to advancing the digitalization of healthcare, Honeywell signed MOUs with the University Hospital Brno, the second largest hospital in the Czech Republic, and Narayana Hrudayalaya Limited (Narayana Health), one of India’s foremost healthcare service providers, to facilitate their digitalization journeys. The strategic partnerships lay the groundwork for the co-development of advanced technologies to aid in the transformation of healthcare delivery.

The initial pilot with University Hospital Brno involves testing skin patches for real-time monitoring of patients’ vital functions and making the data available via mobile app. Looking ahead, Honeywell is in discussions to equip the Department of Internal Cardiology with its smart voice and touchscreen nurse call system as part of a comprehensive update of the hospital information system.

Honeywell and Narayana Health plan to work together on the introduction of new products, establish technology development centers, co-create joint capabilities in technology development and research and undertake the development of fire safety codecs that help ensure an end-to-end life safety system to make hospitals safer. As a technology partner, Honeywell plans to also help enhance and optimize Narayana Health’s digital processes and offer training to its employees.

The healthcare industry is continuously evolving to maintain environments where patients and staff feel safe. With its robust portfolio of healthcare technologies, Honeywell provides innovative solutions that drive better patient outcomes delivered in efficient, safe and secure environments for caregivers and the communities they serve.

Honeywell Safety and Productivity Solutions (SPS) provides products, software and connected solutions that improve productivity, workplace safety and asset performance for our customers across the globe. We deliver on this promise through industry-leading mobile devices, software, cloud technology and automation solutions, the broadest range of personal protective equipment and gas detection technology, and custom-engineered sensors, switches and controls. For more information, please visit: sps.honeywell.com.

Honeywell (www.honeywell.com) is a Fortune 100 technology company that delivers industry-specific solutions that include aerospace products and services; control technologies for buildings and industry; and performance materials globally. Our technologies help aircraft, buildings, manufacturing plants, supply chains, and workers become more connected to make our world smarter, safer, and more sustainable. For more news and information on Honeywell, please visit www.honeywell.com/newsroom.

SourceHoneywell

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.